US Patent Issued to OMEICOS Therapeutics, Max Delbruck-Centrum Fur Molekulare Medizin on July 29 for "Analogs of CYP-eicosanoids for use in treating or preventing a disorder associated with neovascularization and/or inflammation" (German Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,158, issued on July 29, was assigned to OMEICOS Therapeutics GmbH (Berlin) and Max Delbruck-Centrum Fur Molekulare Medizin (Berlin).

"Analogs of CYP-eicosanoids for use in treating or preventing a disorder associated with neovascularization and/or inflammation" was invented by Robert Fischer (Berlin), Wolf-Hagen Schunck (Berlin), Dominik Muller (Berlin), Tim Wesser (Berlin), Anne Konkel (Berlin) and Janine Lossie (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds according to general formula (I) which are metabolically robust analogues of bioactive lipid mediators derived from omega-3 polyunsaturated fa...